アステラス製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/01/18 | 1,909.5 | 1,968.5 | 1,898.5 | 1,960 | +66.5 | +3.5% | 5,799,800 |
2023/01/17 | 1,921 | 1,927 | 1,893.5 | 1,893.5 | -10 | -0.5% | 4,211,500 |
2023/01/16 | 1,890 | 1,917 | 1,885 | 1,903.5 | +16.5 | +0.9% | 5,030,000 |
2023/01/13 | 1,892 | 1,906 | 1,877 | 1,887 | -34.5 | -1.8% | 5,828,200 |
2023/01/12 | 1,913.5 | 1,936.5 | 1,906 | 1,921.5 | +7 | +0.4% | 3,111,500 |
2023/01/11 | 1,903 | 1,919 | 1,896.5 | 1,914.5 | +13 | +0.7% | 4,429,300 |
2023/01/10 | 1,919 | 1,938 | 1,899 | 1,901.5 | -22.5 | -1.2% | 4,021,800 |
2023/01/06 | 1,917.5 | 1,929.5 | 1,913 | 1,924 | +10.5 | +0.5% | 3,584,500 |
2023/01/05 | 1,948.5 | 1,949.5 | 1,908.5 | 1,913.5 | -17.5 | -0.9% | 3,575,900 |
2023/01/04 | 1,990 | 1,993.5 | 1,926 | 1,931 | -75.5 | -3.8% | 4,782,100 |
2022/12/30 | 2,015 | 2,024.5 | 2,004.5 | 2,006.5 | -18.5 | -0.9% | 3,908,600 |
2022/12/29 | 2,016 | 2,026 | 2,003.5 | 2,025 | -8 | -0.4% | 2,900,400 |
2022/12/28 | 2,030 | 2,041 | 2,022.5 | 2,033 | +4 | +0.2% | 2,668,800 |
2022/12/27 | 2,042 | 2,049 | 2,023.5 | 2,029 | -6.5 | -0.3% | 2,252,700 |
2022/12/26 | 2,041 | 2,049 | 2,035.5 | 2,035.5 | +1.5 | +0.1% | 1,208,100 |
2022/12/23 | 2,048.5 | 2,057.5 | 2,026.5 | 2,034 | -17.5 | -0.9% | 3,196,200 |
2022/12/22 | 2,060 | 2,061.5 | 2,037 | 2,051.5 | +3 | +0.1% | 3,988,900 |
2022/12/21 | 2,068 | 2,072.5 | 2,040.5 | 2,048.5 | -23 | -1.1% | 4,760,700 |
2022/12/20 | 2,109.5 | 2,113 | 2,009 | 2,071.5 | -34.5 | -1.6% | 5,154,700 |
2022/12/19 | 2,135 | 2,136 | 2,099 | 2,106 | -42.5 | -2% | 3,938,400 |
2022/12/16 | 2,145.5 | 2,152.5 | 2,133 | 2,148.5 | -17.5 | -0.8% | 4,492,200 |
2022/12/15 | 2,170.5 | 2,188.5 | 2,163 | 2,166 | -20 | -0.9% | 2,809,900 |
2022/12/14 | 2,181.5 | 2,194.5 | 2,172.5 | 2,186 | +17 | +0.8% | 3,893,300 |
2022/12/13 | 2,151.5 | 2,169 | 2,144.5 | 2,169 | +40 | +1.9% | 3,425,800 |
2022/12/12 | 2,125 | 2,140 | 2,121 | 2,129 | -7 | -0.3% | 2,743,800 |
2022/12/09 | 2,100 | 2,143 | 2,098 | 2,136 | +11 | +0.5% | 4,419,700 |
2022/12/08 | 2,129 | 2,134 | 2,108 | 2,125 | +22 | +1% | 5,679,000 |
2022/12/07 | 2,078.5 | 2,111.5 | 2,066 | 2,103 | +11 | +0.5% | 3,896,000 |
2022/12/06 | 2,085 | 2,094 | 2,076 | 2,092 | +3 | +0.1% | 3,164,600 |
2022/12/05 | 2,100 | 2,106 | 2,073 | 2,089 | +4.5 | +0.2% | 3,384,800 |
2022/12/02 | 2,102.5 | 2,129 | 2,064.5 | 2,084.5 | -42.5 | -2% | 4,526,500 |
2022/12/01 | 2,126 | 2,141 | 2,116 | 2,127 | -1 | ±0% | 3,823,400 |
2022/11/30 | 2,120.5 | 2,130.5 | 2,103 | 2,128 | -0.5 | ±0% | 9,308,700 |
2022/11/29 | 2,139.5 | 2,146 | 2,118 | 2,128.5 | -13.5 | -0.6% | 3,331,200 |
2022/11/28 | 2,154.5 | 2,161.5 | 2,132.5 | 2,142 | -3 | -0.1% | 2,640,000 |
2022/11/25 | 2,162 | 2,164 | 2,139.5 | 2,145 | -5 | -0.2% | 2,374,600 |
2022/11/24 | 2,150 | 2,171 | 2,145.5 | 2,150 | +11 | +0.5% | 4,937,800 |
2022/11/22 | 2,121 | 2,149.5 | 2,120 | 2,139 | +34.5 | +1.6% | 4,078,800 |
2022/11/21 | 2,111.5 | 2,119 | 2,100 | 2,104.5 | -3 | -0.1% | 2,861,800 |
2022/11/18 | 2,090 | 2,114 | 2,080.5 | 2,107.5 | +40 | +1.9% | 3,807,600 |
2022/11/17 | 2,056.5 | 2,073.5 | 2,048.5 | 2,067.5 | +7 | +0.3% | 3,231,300 |
2022/11/16 | 2,082.5 | 2,090.5 | 2,058 | 2,060.5 | -40 | -1.9% | 3,632,600 |
2022/11/15 | 2,085 | 2,109 | 2,078.5 | 2,100.5 | +52.5 | +2.6% | 4,700,500 |
2022/11/14 | 2,057.5 | 2,069.5 | 2,041.5 | 2,048 | -28 | -1.3% | 3,690,400 |
2022/11/11 | 2,098 | 2,098 | 2,056 | 2,076 | +7.5 | +0.4% | 5,031,700 |
2022/11/10 | 2,052 | 2,070 | 2,038 | 2,068.5 | +1 | ±0% | 2,928,700 |
2022/11/09 | 2,094.5 | 2,094.5 | 2,059 | 2,067.5 | -20 | -1% | 2,871,500 |
2022/11/08 | 2,073.5 | 2,097 | 2,067.5 | 2,087.5 | +27 | +1.3% | 4,008,500 |
2022/11/07 | 2,064.5 | 2,070.5 | 2,048.5 | 2,060.5 | -10 | -0.5% | 3,640,000 |
2022/11/04 | 2,056 | 2,082.5 | 2,048 | 2,070.5 | -11 | -0.5% | 5,471,200 |
501~
550
件表示中 / 3631件
類似銘柄と比較する
現在ご覧いただいている「アステラス薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
アステラス薬 | 149,100円 | +18.5% | -96.0% | 4.96% | 190.66倍 | 1.74倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
武 田 | 414,600円 | +7.7% | +206.9% | 4.73% | 55.69倍 | 0.95倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
大塚HD | 797,800円 | +14.4% | +120.8% | 1.50% | 17.86倍 | 1.64倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
塩野義 | 217,900円 | +5.7% | +3.9% | 2.63% | 10.84倍 | 1.44倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 441,700円 | +1.7% | -2.9% | 3.62% | 28.98倍 | 1.52倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム